{
  "ptid_time": "023_S_4243_2014-02-26",
  "img_path": "/data/qiuhui/data/adni/images/023_S_4243/2014-02-26/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 85,925 mm³, 82.8% above the reference mean. With a Z-score of 2.40 (99.2th percentile), this represents significant enlargement; hippocampal volume measures 5,260 mm³, 24.5% below the reference mean. With a Z-score of -2.12 (1.7th percentile), this represents significant atrophy; whole brain volume measures 1,129,410 mm³, 9.7% above the reference mean. With a Z-score of 1.28 (89.9th percentile), this represents mild enlargement; entorhinal cortex volume measures 1,714 mm³, 56.8% below the reference mean. With a Z-score of -3.72 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 18,560 mm³, 2.7% above the reference mean. With a Z-score of 0.24 (59.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,798 mm³, 6.8% below the reference mean. With a Z-score of -0.61 (27.1th percentile), this represents normal volume . ",
  "text_data": "Age is 81.3 years. Gender is Male. Education: 18 years. MMSE: 19.0. MoCA: 19.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.52 SUVR (profound elevated); Amyloid beta: 977.70 pg/mL (normal ); Total tau: 422.20 pg/mL (significant elevated); Phosphorylated tau: 39.16 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant hippocampal and entorhinal cortex atrophy, both hallmark features of Alzheimer's disease (AD), alongside elevated T-tau and P-tau (indicating neurodegeneration) and profound amyloid deposition (AV45). The MMSE and MoCA scores (19/30) suggest cognitive impairment, but Aβ is normal, which is atypical for AD but may suggest a tauopathy or mixed pathology.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease or mixed pathology)  \n**Confidence:** **Medium** (due to normal Aβ conflicting with typical AD biomarkers, but tau and structural changes strongly support neurodegeneration)",
  "timestamp": "2025-07-26T03:05:00.265449"
}